Inbar Nardi Agmon

Dr. Inbar Nardi Agmon

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2017 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
IAInbar Nardi Agmon
Inbar Nardi Agmon
EGElad Goldberg
Elad Goldberg
ECEytan Cohen
Eytan Cohen
IKIlan Krause
Ilan Krause

29 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NPNili Schamroth Pravda
Nili Schamroth Pravda
GGGregory Golovchiner
Gregory Golovchiner
GGGustavo Goldenberg
Gustavo Goldenberg
YPYgal Plakht
Ygal Plakht
MWMaya Wiessman
Maya Wiessman
AHAshraf Hamdan
Ashraf Hamdan
Introduction: Atrial fibrillation (AF) recurrence following pulmonary vein isolation (PVI) ablation has clinical significance. Identifying risk factors for AF recurrence is important. We investigated serum albumin (SA) levels (g/dL) as a prognostic factor for the recurrence of AF following cryoballoon PVI ablation. Methods: We included patients who underwent cryoballoon PVI ablation at our institution between the years 2013 and 2018. The primary outcome was recurrence of AF during follow up. Results: Our cohort consisted of 126 patients (67% males, mean age 61.8 ± 10.0 years). The pattern of AF amongst the cohort was paroxysmal in 62.5%, persistent in 25.4%, and longstanding persistent in 6.3%. Those with lower SA levels had a mean AF duration significantly less than those with higher SA levels (2.81 years, 7.34 years, and 6.37 years for SA levels of <3.8, 3.8–4.1, and ≥4.1, respectively; p = 0.003). Patients with lower SA levels were significantly more likely to have had more previous cardioversions and a larger left atrial area and volume. The mean follow-up was 380 days, in which the AF recurrence rate was 20.6%. Patients with lower SA level had significantly more AF recurrences (47.4%, 16.7%, and 2.2% for SA levels of <3.8, 3.8–4.1, and ≥4.1, respectively; p < 0.001). Upon multivariate analysis, an SA level < 3.8 was associated with a higher risk of AF recurrence (OR = 5.422 95% CI 1.134; 25.910; p < 0.001). Conclusion: SA levels were found to be a strong independent marker for AF recurrence following PVI ablation.

7 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IAInbar Nardi Agmon
Inbar Nardi Agmon
OZOsnat Itzhaki Ben Zadok
Osnat Itzhaki Ben Zadok
RKRan Kornowski
Ran Kornowski
The use of immune checkpoint inhibitors (ICIs) as a mono- or adjuvant oncologic treatment is rapidly expanding to most fields of cancer. Alongside their efficacy, ICIs carry the risk of immune-related adverse events (irAEs) arising from misguided immune-mediated response to normal tissues. In the cardiovascular system, the cardiac toxicity of ICIs has been primarily related to the development of an acute, immune-mediated myocarditis; beyond this potentially fatal complication, evidence of an increased risk of cardiovascular events and accelerated atherosclerosis is emerging, as well as reports of other cardiovascular adverse events such as arrythmias, Takotsubo-like syndrome and vascular events. The absence of identified risk factors for cardiotoxic complications, specific monitoring strategies or diagnostic tests, pose challenges to the timely recognition and optimal management of such events. The rising numbers of patients being treated with ICIs make this potential cardiotoxic effect one of paramount importance for further investigation and understanding. This review will discuss the most recent data on different cardiotoxic effects of ICIs treatment.

1 March 2021 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
IAInbar Nardi Agmon
Inbar Nardi Agmon
LPLeor Perl
Leor Perl
TBTamir Bental
Tamir Bental
OZOsnat Itzhaki Ben Zadok
Osnat Itzhaki Ben Zadok
HVHana Vaknin-Assa
Hana Vaknin-Assa
RKRan Kornowski
Ran Kornowski

27 November 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
IAInbar Nardi Agmon
Inbar Nardi Agmon
AHAshraf Hamdan
Ashraf Hamdan
AEAlon Eisen
Alon Eisen
KOKatia Orvin
Katia Orvin
APAvital Porter
Avital Porter
OZOsnat Itzhaki Ben Zadok
Osnat Itzhaki Ben Zadok

7 July 2023 in The American Journal of Cardiology
Verified
Journal Article
Closed access
IAInbar Nardi Agmon
Inbar Nardi Agmon
GCGali Cohen
Gali Cohen
OZOsnat Itzhaki Ben Zadok
Osnat Itzhaki Ben Zadok
DSDavid M Steinberg
David M Steinberg
RKRan Kornowski
Ran Kornowski
YGYariv Gerber
Yariv Gerber